Immunotherapy in pancreatic ductal adenocarcinoma: an emerging entity?
Author:
Funder
National Cancer Institute
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/28/12/2950/24169071/mdx503.pdf
Reference85 articles.
1. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer;Conroy;N Engl J Med,2011
2. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine;Von Hoff;N Engl J Med,2013
3. Molecular signature of pancreatic adenocarcinoma: an insight from genotype to phenotype and challenges for targeted therapy;Sahin;Expert Opin Ther Targets,2016
4. Immune surveillance of tumors;Swann;J Clin Invest,2007
5. Cancer immunoediting: from immunosurveillance to tumor escape;Dunn;Nat Immunol,2002
Cited by 80 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Glycogen synthase kinase 3β: the nexus of chemoresistance, invasive capacity, and cancer stemness in pancreatic cancer;Cancer Drug Resistance;2024-01-31
2. Emerging Prognostic and Predictive Factors in Pancreatic Cancer;Modern Pathology;2023-11
3. Pancreatic adenocarcinoma — current trends in diagnosis and treatment;Oncology in Clinical Practice;2023-08-23
4. Case report: A case study on the treatment using icaritin soft capsules in combination with lenvatinib achieving impressive PR and stage reduction in unresectable locally progressive pancreatic cancer and a literature review;Frontiers in Genetics;2023-04-20
5. Palmitoyl transferases act as novel drug targets for pancreatic cancer;Journal of Translational Medicine;2023-04-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3